Cargando…
Advances in biomarker development and potential application for preeclampsia based on pathogenesis
Preeclampsia (PE) is a pregnancy-specific complication that seriously threatens the health and safety of mothers and infants. The etiology of PE has not been fully elucidated, and no effective treatments are currently available. A pregnant woman with PE often has to make a tough choice on either end...
Autores principales: | Liu, Nan, Guo, Yu-Na, Gong, Li-Kun, Wang, Bing-Shun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575783/ https://www.ncbi.nlm.nih.gov/pubmed/33103113 http://dx.doi.org/10.1016/j.eurox.2020.100119 |
Ejemplares similares
-
Copy Number Analyses Identified a Novel Gene: APOBEC3A Related to Lipid Metabolism in the Pathogenesis of Preeclampsia
por: Liu, Nan, et al.
Publicado: (2022) -
Bioinformatics methods in biomarkers of preeclampsia and associated potential drug applications
por: Peng, Ying, et al.
Publicado: (2022) -
Bioinformatic analysis reveals lysosome-related biomarkers and molecular subtypes in preeclampsia: novel insights into the pathogenesis of preeclampsia
por: Chen, Yao, et al.
Publicado: (2023) -
Potential Protein Biomarkers for Preeclampsia
por: He, Andong, et al.
Publicado: (2020) -
LncRNAs Expression in Preeclampsia Placenta Reveals the Potential Role of LncRNAs Contributing to Preeclampsia Pathogenesis
por: He, Xiaoju, et al.
Publicado: (2013)